Bergen, Norway 26 Januar 2023 A new partnership with Goethe University Frankfurt am Main strengthen Lifecare's access to expertise and increase our recruitment base. Lifecare CSO Prof. Dr. Dr. Andreas Pfützner will present Lifecare's technology at the 16thInternational Conference on "Advanced Technologies & Treatments for Diabetes" inBerlin (ATTD22-25 February 2023 ). The Norwegian Catapult Centre has awarded yet another grant to Lifecare. Read more in Lifecare's newsletter published today: https://lifecare.no/news/information-from-lifecare-january-2023/ This is Lifecare: Lifecare is aBergen -based technology company developing a miniaturized implantable long-term sensor for correct and continuous monitoring of blood sugar in people with diabetes. The Company's patented technology also has the potential for use in various biomarkers.Lifecare AS is listed on Euronext Growth (LIFE). Further informationJoacim Holter , CEO,Lifecare AS , joacim.holter@lifecare.no, +47 40 05 90 40This stock exchange announcement was published byJoacim Holter , CEO atLifecare AS , on25.1.23 at13:33 CET .
Click here for more information
© Oslo Bors ASA, source